 Mycosis fungoides Sezary syndrome review pathogenesis diagnosis therapy Mycosis fungoides MF Sezary syndrome SS non-Hodgkin lymphomas T-cell phenotype cutaneous involvement predominant feature disorders common patients medical oncologists assistance management development advanced laboratory techniques molecular genetics cell-surface phenotyping understanding pathogenesis identification responsible etiologic factors myriad treatment options topical approaches systemic chemotherapy external radiation Currently extensive trials underway potential benefits agents interferons monoclonal antibodies retinoids novel biologic response modifiers chemotherapeutics therapies phase II trials comparative trials optimal therapies Performance trials priority